查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855796

2025年人工智慧（AI）賦能的罕見疾病診斷全球市場報告

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧（AI）輔助罕見疾病診斷的市場規模呈指數級成長，預計從2024年的15.4億美元成長到2025年的19.9億美元，複合年成長率（CAGR）高達29.1%。這一歷史性成長與醫療保健領域人工智慧（AI）的日益普及、罕見疾病研究投入的增加、早期診斷意識的提高、醫療基礎設施的不斷完善以及政府對數位醫療舉措的大力支持密切相關。

預計未來幾年，人工智慧（AI）賦能的罕見疾病診斷市場將呈指數級成長，到2029年市場規模將達到55億美元，複合年成長率（CAGR）為28.9%。預測期內的成長主要歸功於機器學習演算法的廣泛應用、個人化醫療需求的不斷成長、人工智慧新興企業與醫院合作的日益密切、基因組數據的可用性不斷提高以及醫療保健數位化的不斷提高。預測期內的關鍵趨勢包括深度學習模型的進步、預測性診斷技術的創新、醫學數據自然語言處理的發展、多組體學整合研究以及人工智慧驅動成像技術的持續改進。

自體免疫疾病盛行率的不斷上升預計將推動人工智慧驅動的罕見疾病診斷市場擴張。自體免疫疾病是指免疫系統錯誤地攻擊自體健康細胞，導致發炎和組織損傷。越來越多的人出現免疫系統功能障礙，推動了對早期診斷、先進治療和持續症狀管理的需求。人工智慧驅動的罕見疾病診斷能夠快速識別複雜疾病，支援個人化治療方案，並提高診斷準確性，從而幫助管理自體免疫疾病。例如，澳洲健康與福利研究所於2024年6月報告稱，到2022年，澳洲約有51.4萬人（佔總人口的2.0%）將患有類風濕性關節炎，這凸顯了對準確診斷和治療日益成長的需求。因此，自體免疫疾病發生率的上升正在推動人工智慧驅動的罕見疾病診斷市場的成長。

人工智慧驅動的罕見疾病診斷市場中的企業正致力於開發最尖端科技，例如整合基因組診斷解決方案，旨在提高診斷準確性、縮短等待時間並深入了解複雜的遺傳疾病。整合基因組診斷解決方案將全基因組定序與人工智慧主導的分析相結合，從而提供全面的遺傳資訊。例如，2023年10月，英國生物技術公司牛津奈米孔技術公司（Oxford Nanopore Technologies）和美國人工智慧公司Fabric Genomics宣布推出一項整合全基因組定序解決方案。該合作將快速測序與基於人工智慧的變異解讀相結合，從而實現對罕見疾病的快速準確診斷。該系統將即時奈米孔定序與人工智慧驅動的基因組分析相結合，能夠快速檢測罕見基因突變，為臨床醫生提供可操作的見解，並提高診斷速度和準確性，尤其是在兒童領域。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧 (AI) 賦能的罕見疾病診斷：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球人工智慧（AI）賦能的罕見疾病診斷市場：成長率分析
  • 全球人工智慧（AI）賦能的罕見疾病診斷市場表現：規模與成長，2019-2024年
  • 全球人工智慧（AI）賦能的罕見疾病診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球人工智慧 (AI) 賦能的罕見疾病診斷：潛在市場規模 (TAM)

第6章 市場細分

  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按組件、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 軟體
  • 硬體
  • 服務
  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按技術、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 機器學習
  • 深度學習
  • 自然語言處理
  • 電腦視覺
  • 其他技術
  • 全球人工智慧（AI）賦能的罕見疾病診斷市場：按部署模式、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 雲端基礎的
  • 本地部署
  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按診斷類型、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 遺傳性疾病
  • 自體免疫疾病
  • 代謝紊亂
  • 感染疾病
  • 其他診斷類型
  • 全球基於人工智慧（AI）的罕見疾病診斷市場（按最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年）
  • 醫院
  • 診斷中心
  • 研究所
  • 專科診所
  • 其他最終用戶
  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按軟體、類型、效能和預測進行細分，2019-2024年、2024-2029年、2034年
  • 臨床決策支持
  • 數據分析平台
  • 基因組分析工具
  • 機器學習演算法
  • 診斷報告軟體
  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按硬體、類型、效能和預測進行細分，2019-2024年、2024-2029年、2034年
  • 定序設備
  • 影像設備
  • 實驗室設備
  • 計算伺服器
  • 診斷感測器
  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按服務、類型、效能和預測細分，2019-2024年、2024-2029年、2034年
  • 諮詢服務
  • 實施與整合
  • 培訓和支持
  • 資料管理服務
  • 維護和升級

第7章 區域和國家分析

  • 全球基於人工智慧（AI）的罕見疾病診斷市場：按地區、績效和預測分類，2019-2024年、2024-2029年、2034年
  • 全球基於人工智慧（AI）的罕見疾病診斷市場：國家/地區、績效及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧（AI）賦能的罕見疾病診斷市場：競爭格局
  • 人工智慧（AI）賦能的罕見疾病診斷市場：公司概況
    • Ambry Genetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • MedGenome Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sophia Genetics SA Overview, Products and Services, Strategy and Financial Analysis
    • Variantyx Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Facial Dysmorphology Novel Analysis Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Atropos Health Inc.
  • Congenica Ltd.
  • Saventic Care Sp. z oo
  • Rapid Innovation LLC
  • Centogene NV
  • Impilo AB
  • ThinkGenetic Inc.
  • ClairLabs Ltd.
  • 3billion Inc.
  • OpenEvidence Inc.
  • GenomeUp SRL
  • Mendel.ai Inc.
  • RareSum GmbH
  • DeepRare AI Solutions
  • Zebra-Llama Project

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年人工智慧（AI）賦能的罕見疾病診斷市場：提供新機會的國家
  • 2029年人工智慧（AI）賦能的罕見疾病診斷市場：蘊藏新機會的細分領域
  • 2029年人工智慧（AI）賦能的罕見疾病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38445

Artificial intelligence (AI)-powered rare disease diagnosis involves the application of advanced algorithms and machine learning techniques to accurately identify uncommon medical conditions. These systems process complex patient data, including genetic, clinical, and imaging information, to uncover patterns that may be overlooked by traditional diagnostic approaches.

The primary components of artificial intelligence (AI)-powered rare disease diagnosis include software, hardware, and services. Software comprises programs, data, and instructions that guide a computer or device in performing specific tasks. Technologies involved include machine learning, deep learning, natural language processing, computer vision, and others. Deployment modes consist of cloud-based and on-premises solutions. Diagnosis types cover genetic disorders, autoimmune disorders, metabolic disorders, infectious diseases, and more, with end users including hospitals, diagnostic centers, research institutes, specialty clinics, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-powered rare disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered rare disease diagnosis market statistics, including the artificial intelligence (AI)-powered rare disease diagnosis industry global market size, regional shares, competitors with the artificial intelligence (AI)-powered rare disease diagnosis market share, detailed artificial intelligence (AI)-powered rare disease diagnosis market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered rare disease diagnosis industry. This artificial intelligence (AI)-powered rare disease diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered rare disease diagnosis market size has grown exponentially in recent years. It will grow from $1.54 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 29.1%. The growth observed during the historic period can be linked to increasing adoption of artificial intelligence (AI) in healthcare, higher investment in rare disease research, greater awareness of early diagnosis, expansion of healthcare infrastructure, and stronger government support for digital health initiatives.

The artificial intelligence (AI)-powered rare disease diagnosis market size is expected to see exponential growth in the next few years. It will grow to $5.50 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%. The growth projected for the forecast period can be attributed to wider integration of machine learning algorithms, rising demand for personalized medicine, growing collaborations between AI startups and hospitals, increased availability of genomic data, and ongoing digitalization of healthcare. Key trends during the forecast period include advancements in deep learning models, innovations in predictive diagnostics, developments in natural language processing for medical data, research in multi-omics integration, and continuous enhancements in AI-driven imaging technologies.

The growing prevalence of autoimmune disorders is expected to drive the expansion of the AI-powered rare disease diagnosis market. Autoimmune disorders occur when the immune system mistakenly attacks the body's healthy cells, resulting in inflammation and tissue damage. The rising number of individuals experiencing immune system dysfunctions has led to a higher demand for early diagnosis, advanced treatments, and continuous symptom management. AI-powered rare disease diagnosis helps manage autoimmune conditions by quickly identifying complex diseases, supporting personalized treatment plans, and improving diagnostic accuracy. For example, the Australian Institute of Health and Welfare reported in June 2024 that approximately 514,000 people (2.0%) in Australia were living with rheumatoid arthritis in 2022, highlighting the growing need for accurate diagnosis and treatment. As such, the increasing incidence of autoimmune disorders is driving market growth in AI-powered rare disease diagnosis.

Companies in the AI-powered rare disease diagnosis market are focusing on developing cutting-edge technologies such as unified genomic diagnostic solutions to improve diagnostic precision, reduce waiting times, and offer deeper insights into complex genetic conditions. A unified genomic diagnostics solution integrates whole-genome sequencing with AI-driven analysis to provide comprehensive genetic insights. For example, in October 2023, Oxford Nanopore Technologies, a UK-based biotechnology firm, and Fabric Genomics, a US-based AI-driven company, launched a unified whole-genome sequencing solution. This collaboration combines rapid sequencing with AI-based variant interpretation, enabling faster and more accurate diagnosis of rare diseases. The system integrates real-time nanopore sequencing with AI-powered genomic analysis to quickly detect rare genetic variants, offering clinicians actionable insights that enhance diagnostic speed and accuracy, especially in pediatric care.

In May 2022, Sema4, a US-based AI-driven genomic and clinical data intelligence platform, acquired GeneDx Holdings Corp. in a bid to strengthen its position in rare disease diagnostics. The acquisition, which was made for an undisclosed amount, allows Sema4 to merge GeneDx's vast genomic data resources with its AI-powered platforms. This integration is aimed at improving diagnostic precision and accelerating personalized medicine. GeneDx Holdings, a US-based biotechnology and medical diagnostics company, specializes in using genomics and artificial intelligence to diagnose rare genetic diseases.

Major players in the artificial intelligence (AI)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Facial Dysmorphology Novel Analysis, Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project.

North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered rare disease diagnosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered rare disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered rare disease diagnosis market includes revenues earned by entities by providing services such as genomic sequencing analysis, clinical data integration, artificial intelligence (AI)-based imaging interpretation, predictive analytics for rare diseases, and personalized treatment recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered rare disease diagnosis market also includes sales of genetic testing kits, imaging scanners, biosensors, lab automation instruments, point-of-care testing devices, wearable health monitors, sequencing machines, microfluidic chips, and pathology slide scanners. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-powered rare disease diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered rare disease diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered rare disease diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning; Deep Learning; Natural Language Processing; Computer Vision; Other Technologies
  • 3) By Deployment Mode: Cloud-Based; On-Premises
  • 4) By Diagnosis Type: Genetic Disorders; Autoimmune Disorders; Metabolic Disorders; Infectious Diseases; Other Diagnosis Types
  • 5) By End-User: Hospitals; Diagnostic Centers; Research Institutes; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Software: Clinical Decision Support; Data Analytics Platforms; Genomic Interpretation Tools; Machine Learning Algorithms; Diagnostic Reporting Software
  • 2) By Hardware: Sequencing Instruments; Imaging Devices; Laboratory Equipment; Computational Servers; Diagnostic Sensors
  • 3) By Services: Consulting Services; Implementation And Integration; Training And Support; Data Management Services; Maintenance And Upgrades
  • Companies Mentioned: Ambry Genetics Corporation; MedGenome Inc.; Sophia Genetics SA; Variantyx Inc.; Facial Dysmorphology Novel Analysis; Atropos Health Inc.; Congenica Ltd.; Saventic Care Sp. z o.o.; Rapid Innovation LLC; Centogene N.V.; Impilo AB; ThinkGenetic Inc.; ClairLabs Ltd.; 3billion Inc.; OpenEvidence Inc.; GenomeUp S.R.L.; Mendel.ai Inc.; RareSum GmbH; DeepRare AI Solutions; Zebra-Llama Project
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Characteristics

3. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Trends And Strategies

4. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Segmentation

  • 6.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning
  • Deep Learning
  • Natural Language Processing
  • Computer Vision
  • Other Technologies
  • 6.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premises
  • 6.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Disorders
  • Autoimmune Disorders
  • Metabolic Disorders
  • Infectious Diseases
  • Other Diagnosis Types
  • 6.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Specialty Clinics
  • Other End-Users
  • 6.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Decision Support
  • Data Analytics Platforms
  • Genomic Interpretation Tools
  • Machine Learning Algorithms
  • Diagnostic Reporting Software
  • 6.7. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Instruments
  • Imaging Devices
  • Laboratory Equipment
  • Computational Servers
  • Diagnostic Sensors
  • 6.8. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation And Integration
  • Training And Support
  • Data Management Services
  • Maintenance And Upgrades

7. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 9.1. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 9.2. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 10.1. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 11.1. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 11.2. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 12.1. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 13.1. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 14.1. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 14.2. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 15.1. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 16.1. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 17.1. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 18.1. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 19.1. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 20.1. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 21.1. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 22.1. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 23.1. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 23.2. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 24.1. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 24.2. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 25.1. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 25.2. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 26.1. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 26.2. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 27.1. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 28.1. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 28.2. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 29.1. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 29.2. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Company Profiles
    • 30.2.1. Ambry Genetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. MedGenome Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sophia Genetics SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Variantyx Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Facial Dysmorphology Novel Analysis Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Other Major And Innovative Companies

  • 31.1. Atropos Health Inc.
  • 31.2. Congenica Ltd.
  • 31.3. Saventic Care Sp. z o.o.
  • 31.4. Rapid Innovation LLC
  • 31.5. Centogene N.V.
  • 31.6. Impilo AB
  • 31.7. ThinkGenetic Inc.
  • 31.8. ClairLabs Ltd.
  • 31.9. 3billion Inc.
  • 31.10. OpenEvidence Inc.
  • 31.11. GenomeUp S.R.L.
  • 31.12. Mendel.ai Inc.
  • 31.13. RareSum GmbH
  • 31.14. DeepRare AI Solutions
  • 31.15. Zebra-Llama Project

32. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

34. Recent Developments In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

35. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer